Capital Fund Management (CFM)
GMED icon

Capital Fund Management (CFM)’s Globus Medical GMED Stock Holding History

Capital Fund Management (CFM)’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,548
Closed -$3.58M – 2210
2026
Q1 		$3.58M Sell
41,548
-63,486
-60% -$5.7M 0.02% 1073
2025
Q4 		$9.17M Sell
105,034
-64,377
-38% -$4.89M 0.03% 883
2025
Q3 		$9.7M Buy
169,411
+84,778
+100% +$4.88M 0.03% 852
2025
Q2 		$5M Buy
+84,633
New +$5.47M 0.01% 1136
2024
Q2 		– Sell
-39,133
Closed -$2.1M – 1981
2024
Q1 		$2.1M Buy
+39,133
New +$2.1M 0.01% 1415
2023
Q4 		– Sell
-105,654
Closed -$5.25M – 2179
2023
Q3 		$5.25M Sell
105,654
-8,837
-8% -$494K 0.02% 898
2023
Q2 		$6.82M Buy
114,491
+77,347
+208% +$4.41M 0.03% 716
2023
Q1 		$2.1M Buy
+37,144
New +$2.38M 0.01% 1045
2019
Q1 		– Sell
-15,400
Closed -$667K – 1834
2018
Q4 		$667K Sell
15,400
-26,700
-63% -$1.33M 0.01% 1254
2018
Q3 		$2.39M Sell
42,100
-38,200
-48% -$2.01M 0.01% 1028
2018
Q2 		$4.05M Buy
+80,300
New +$4.19M 0.02% 817

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Fund Management (CFM)'s GMED Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 41,548 shares — an estimated $3.58M sold.

Capital Fund Management (CFM) first reported a position in GMED in Q2 2018 and held it in 11 quarters. The position peaked at $9.7M in Q3 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 41,548 Globus Medical shares in Q2 2026, an estimated $3.58M.
  • Capital Fund Management (CFM) first reported a position in Globus Medical in Q2 2018 and held it in 11 quarters.
  • Capital Fund Management (CFM)'s Globus Medical position peaked at $9.7M in Q3 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.